Navigation Links
Short latencies shown for cancer in young workers with exposures to electro-magnetic fields
Date:8/15/2011

Jerusalem, August 14, 2011 A study conducted by Hebrew University researchers has found that that there can be very short latency periods between the time of exposure and development of cancer in workers in tasks with intense or prolonged exposure to electro-magnetic fields (EMFs). Previous studies have described excess risks for cancer from such high occupational exposures. However, none have addressed the issue of short latency periods from high exposure.

In the past two decades, 47 cancer patients - including 8 with multiple primaries - came to the Unit of Occupational and Environmental Medicine with histories of prior occupational exposure to various types and intensities of EMFs. In 15 cases, the latency periods between first exposure and diagnosis was less than 5 years, and 12 with latencies between 5 and 10 years.

High exposure to EMFs occurs with tasks involving fixing of radar equipment, sitting in vehicles with antennas and communication equipment, carrying radio equipment on waist or back all day, or working in offices located very close to powerful transmitting antenna, or 'situation rooms' that are packed full of communications equipment and radios. Periods of exposure to EMFs among the group of patients ranged from five months to 33 years. In almost all, exposures to EMFs were during military service.

Most of the patients were in their early twenties and had extremely short latent periods. In the < 5 year latency group, there were 8 haematolymphatic cancers and 9 solid tumors that included testis, head and neck (including brain), and gastro-intestinal tract, including two with two primary cancers. The patterns of latency for different types of tumors suggest a coherent and biologically plausible pattern in relation to the onset of exposure to EMFs.

The report, which was recently published in the European Journal of Oncology, was written by Dr. Yael Stein, researcher Or Levy-Nativ and Prof. Elihu D. Richter of the Hebrew University's Braun School of Public Health and Community Medicine. Stein is preparing to do her Ph.D. on modeling of EMF exposure sources and penetration into the body.

Lloyd Morgan of the Environmental Health Trust, a U.S. scientific watchdog group, wrote, "The importance of this paper cannot be overstated. It suggests that a shift is required towards a new paradigm that non-ionizing radiation could be a universal carcinogen similar to ionizing radiation".

The study points to the need for better understanding of the carcinogenic potency of EMF and better protective measures against them.

"These young men and women are the nation's eyes and ears," wrote Prof. Richter in a letter to Israel's attorney general. "Our results state the case for protecting those who are protecting us. This means recognizing their risks now and taking action to protect them from high exposures to radiofrequency/microwaves."


'/>"/>

Contact: Jerry Barach
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert

Related medicine news :

1. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
2. For Some Breast Cancer Patients, Shorter Radiation Works Well
3. Short-term radiation therapy successful on breast cancer
4. No End In Sight To The Armour Thyroid Shortage?
5. WHI data confirm short-term heart disease risks of combination menopausal hormone therapy
6. Americans Falling Short on Heart-Healthy Fruits and Vegetables
7. Website for Nursing Jobs Launches -- Streamlined Job Board Created to Address Nursing Shortage
8. Los Angeles Jewish Home Adds Short-Term Rehabilitative Care to Family of Services
9. Newer cornea transplant surgery shows short- and long-term promise
10. Short on specialized intensive care physicians, team-based approach improves ICU outcomes
11. Apex Heart Care, First Arizona Clinic to Install Shape-HF; New Medical Device Measures Patient Physiology to Define Shortness of Breath
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp ... in and around the greater Phoenix metropolitan region, is announcing a charity event ... mission of the Homeless Youth Connection is to promote community awareness of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, ... residential and commercial clients in the northern Alabama and Georgia regions, is embarking ... Since 1977, Nobis Works has built a network of support and education facilities ...
(Date:12/7/2016)... ... December 07, 2016 , ... Students attending Envision’s ... unique opportunity to get hands-on experience in an emergency medical simulation, When Care ... to gain invaluable, real-life medical skills that are critical success in a future ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
(Date:12/7/2016)... PHILADELPHIA, PA (PRWEB) , ... December 07, 2016 ... ... story of a women growing up with a schizophrenic mother in a unique, ... social worker who specializes in treating trauma and addictive disorders at her private ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... YORK , December 8, 2016 ... focused on the research, distribution, and marketing of pharmaceutical ... affected by patent protection and expiration. Additionally, these firms ... Healthcare sector as a whole. Up for review this ... ), Synergy Pharmaceuticals Inc. (NASDAQ: SGYP ), ...
(Date:12/8/2016)... DES MOINES, Iowa , Dec. 8, 2016 ... STLT), a pharmaceutical company advancing technologies designed to ... the appointment of Chitra Edwin , Ph.D., ... and Compliance. Dr. Edwin will provide leadership for ... planning for regulatory approvals, preparation of regulatory submissions, ...
(Date:12/7/2016)... , Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial ... 37 biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar ... Japan , Kenya , ... , China , Slovakia , ... & 2 diabetes mellitus. The patent on Lantus expired in 2014. ...
Breaking Medicine Technology: